At risk mental state

Last updated

At risk mental state is the clinical presentation of those considered at risk of developing psychosis or schizophrenia. [1] Such states were formerly considered treated as prodromes, emerging symptoms of psychosis, but this view is no longer prevalent as a prodromal period cannot be confirmed unless the emergence of the condition has occurred. [2]

The original specialist service for those with subclinical symptoms of psychosis was The Pace Clinic [3] in Melbourne, Australia. [4] Other clinics have since developed around the world. [5] [6] [7] [8]

There has been some considerable development of how the concept can be applied clinically. [9] [10] [11] [12]

Assessed during the structured interview developed by PACE[ clarification needed ]. [13]

See also

References

  1. ↑ Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A (1996). "Monitoring and care of young people at incipient risk of psychosis". Schizophr Bull. 22 (2): 283–303. doi: 10.1093/schbul/22.2.283 . PMID   8782287.
  2. ↑ Yung, A. R.; McGorry, P. D. (1996-01-01). "The Prodromal Phase of First-episode Psychosis: Past and Current Conceptualizations". Schizophrenia Bulletin. 22 (2): 353–370. doi:10.1093/schbul/22.2.353. ISSN   0586-7614.
  3. ↑ "ORYGEN Youth Health". Archived from the original on 2009-10-24. Retrieved 2011-08-04.
  4. ↑ Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A (1996). "Monitoring and care of young people at incipient risk of psychosis". Schizophr Bull. 22 (2): 283–303. doi: 10.1093/schbul/22.2.283 . PMID   8782287.
  5. ↑ Broome MR, Woolley JB, Johns LC, et al. (August 2005). "Outreach and support in south London (OASIS): implementation of a clinical service for prodromal psychosis and the at risk mental state". Eur. Psychiatry. 20 (5–6): 372–8. doi:10.1016/j.eurpsy.2005.03.001. PMID   16171652. S2CID   27207646.
  6. ↑ PRIME
  7. ↑ (COPE)
  8. ↑ "Emory University". Archived from the original on 2011-07-22. Retrieved 2011-08-04.
  9. ↑ Yung AR, Phillips LJ, Yuen HP, et al. (March 2003). "Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group". Schizophr. Res. 60 (1): 21–32. doi:10.1016/S0920-9964(02)00167-6. PMID   12505135. S2CID   31342026.
  10. ↑ McGorry PD, Yung AR, Phillips LJ, et al. (October 2002). "Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms" . Arch. Gen. Psychiatry. 59 (10): 921–8. doi: 10.1001/archpsyc.59.10.921 . hdl: 10536/DRO/DU:30151296 . PMID   12365879.
  11. ↑ Morrison AP, French P, Parker S, et al. (May 2007). "Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk". Schizophr Bull. 33 (3): 682–7. doi:10.1093/schbul/sbl042. PMC   2526150 . PMID   16973786.
  12. ↑ Schäfer Amminger; Papageorgiou Harrigan; Cotton McGorry, Berger (2008). "Indicated Prevention of Psychotic Disorders with Long-Chainomega-3 Fatty Acids: A Randomized, Placebo-Controlled Trial". Schizophrenia Research. 102 (1–3): 252. doi:10.1016/s0920-9964(08)70758-8. S2CID   53301111.
  13. ↑ Yung AR, Yuen HP, McGorry PD, et al. (2005). "Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States". Aust N Z J Psychiatry. 39 (11–12): 964–71. doi:10.1080/j.1440-1614.2005.01714.x. PMID   16343296. S2CID   145477493.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.